All Companies

LLYCongressional Stock Trades

Eli Lilly & Co.

Pharmaceutical Preparations

Congressional stock trades in Eli Lilly & Co. (LLY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

53

Politicians Trading

22

Last Traded

Jul 10, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$1,001 - $15,000+31.28%
Angus S. King Jr.IJan 26, 2026Dec 29, 2025Buy$1,001 - $15,000+6.88%
Markwayne MullinRJan 16, 2026Dec 29, 2025Buy$15,001 - $50,000+6.88%
John BoozmanRDec 8, 2025Nov 21, 2025Sell$1,001 - $15,000+8.80%
Shelley Moore CapitoRNov 4, 2025Oct 24, 2025Buy$1,001 - $15,000+39.67%
John BoozmanRSep 12, 2025Aug 22, 2025Buy$1,001 - $15,000+62.00%
John BoozmanRSep 12, 2025Aug 11, 2025Buy$1,001 - $15,000+81.50%
Tommy TubervilleRMay 15, 2025Apr 15, 2025Sell$15,001 - $50,000+52.27%
Ashley MoodyRMar 22, 2025Mar 6, 2025Buy$100,001 - $250,000+26.31%
Ron WydenDFeb 21, 2025Feb 10, 2025Sell$50,001 - $100,000+32.69%
Ron WydenDFeb 21, 2025Jan 22, 2025Buy$50,001 - $100,000+52.91%

Price History

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.